Bridgeway Capital Management’s T2 Biosystems, Inc TTOO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-57
| Closed | -$32K | – | 1478 |
|
2022
Q3 | $32K | Hold |
57
| – | – | ﹤0.01% | 1371 |
|
2022
Q2 | $46K | Hold |
57
| – | – | ﹤0.01% | 1289 |
|
2022
Q1 | $148K | Hold |
57
| – | – | ﹤0.01% | 1220 |
|
2021
Q4 | $146K | Hold |
57
| – | – | ﹤0.01% | 1188 |
|
2021
Q3 | $259K | Sell |
57
-60
| -51% | -$273K | ﹤0.01% | 1177 |
|
2021
Q2 | $693K | Sell |
117
-8
| -6% | -$47.4K | 0.01% | 979 |
|
2021
Q1 | $1.01M | Buy |
125
+70
| +127% | +$567K | 0.02% | 861 |
|
2020
Q4 | $341K | Sell |
55
-26
| -32% | -$161K | 0.01% | 1084 |
|
2020
Q3 | $550K | Hold |
81
| – | – | 0.01% | 850 |
|
2020
Q2 | $514K | Buy |
81
+50
| +161% | +$317K | 0.01% | 848 |
|
2020
Q1 | $100K | Hold |
31
| – | – | ﹤0.01% | 1176 |
|
2019
Q4 | $181K | Buy |
31
+1
| +3% | +$5.84K | ﹤0.01% | 1206 |
|
2019
Q3 | $375K | Hold |
30
| – | – | 0.01% | 1044 |
|
2019
Q2 | $252K | Hold |
30
| – | – | ﹤0.01% | 1139 |
|
2019
Q1 | $395K | Hold |
30
| – | – | ﹤0.01% | 1090 |
|
2018
Q4 | $452K | Hold |
30
| – | – | 0.01% | 1028 |
|
2018
Q3 | $1.12M | Hold |
30
| – | – | 0.01% | 838 |
|
2018
Q2 | $1.16M | Hold |
30
| – | – | 0.01% | 823 |
|
2018
Q1 | $974K | Hold |
30
| – | – | 0.01% | 852 |
|
2017
Q4 | $618K | Sell |
30
-17
| -36% | -$350K | 0.01% | 1027 |
|
2017
Q3 | $991K | Buy |
47
+20
| +74% | +$422K | 0.01% | 848 |
|
2017
Q2 | $436K | Hold |
27
| – | – | 0.01% | 1129 |
|
2017
Q1 | $715K | Buy |
+27
| New | +$715K | 0.01% | 934 |
|